LAKESHORE BIOPHARMA CO LTD (LSB) Stock Income Statement
USA - NASDAQ:LSB - KYG9845F2080 - Common Stock
0.627 USD
-0.16 (-20.68%)
0.5399 USD
-0.09 (-13.89%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 614.96M | 573.42M | 687.20M | 0.00 | 0.00 | |||
| Cost Of Goods | 107.77M | 117.69M | 153.36M | 117.07M | 59.66M | |||
| Gross Profit | 507.19M | 455.73M | 533.84M | 385.88M | 197.36M | |||
| Operating Expenses | 556.77M | 744.15M | 673.22M | 560.00K | 0.00 | |||
| Research and Development | 146.37M | 302.80M | 318.70M | 211.22M | 94.39M | |||
| Selling, General, and Administrative Expenses | 410.40M | 441.35M | 354.52M | 550.00K | 228.82M | |||
| Operating Income | -49.58M | -288.42M | -139.38M | -560.00K | 0.00 | |||
| Interest Income/Expense | -15.74M | -44.34M | -30.86M | -3.28M | -29.69M | |||
| Other Income/Expense | 1.10M | 34.98M | 25.89M | 3.29M | -18.83M | |||
| Non Recurring Items | -36.72M | -157.42M | N/A | 0.00 | N/A | |||
| Income Before Taxes | -100.93M | -455.19M | -144.35M | -550.00K | 0.00 | |||
| Income Tax | -946.90K | -21.73M | 1.13M | 4.94M | 17.45M | |||
| Net Income | -99.98M | -433.46M | -283.47M | -550.00K | 0.00 | |||
| EBITDA | -12.93M | -246.23M | -102.69M | 30.59M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.22 | -40.54 | -30.46 | -0.03 | 0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 82.47% | 79.48% | 77.68% | N/A | N/A | |||
| Profit Margin | -16.26% | -75.59% | -41.25% | N/A | N/A | |||
| Operating Profit Margin | -8.06% | -50.30% | -20.28% | N/A | N/A | |||
All data in CNY